Recent Updates
Recently added Catalysts
GEHC Positive Sentiment

GE HealthCare to announce third quarter 2026 results on October 28, 2026

Wednesday, October 7, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: GE HealthCare will announce its third quarter 2026 financial results on October 28, 2026. The announcement will occur before the market opens, followed by a conference call and webcast at 8:30 a.m. ET. This event allows investors to gain insights into the company's performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • GE HealthCare is set to announce its financial results, indicating ongoing operations.
  • The scheduled conference call provides transparency and engagement with investors.
  • The announcement reflects the company's commitment to timely financial reporting.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
2.5%
average across 3 past catalysts
Lead asset
PET MPI
Phase 3 · Coronary Artery Disease (CAD)

Full Press Release Details

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also wil

Frequently Asked Questions

When will GE HealthCare announce its Q3 2026 results?

GE HealthCare will announce its Q3 2026 results on October 28, 2026.

What time is the conference call for Q3 2026 results?

The conference call will take place at 8:30 a.m. Eastern Time.

How can I access the webcast for the earnings call?

The webcast can be accessed at https://investor.gehealthcare.com/news-events/events.

What is the significance of the earnings release?

The earnings release provides insights into GE HealthCare's financial performance.

ShareAdd on Google
Tags: GEHC GE HealthCare financial results Q3 2026 earnings call investor relations
Last updated: Oct 7, 2026

Biotech snapshot

Cash runway
$2079M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PET MPIPhase 3
Coronary Artery Disease (CAD) →

Catalyst track record

+32%
best trade around GEHC's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for GEHC.

See every catalyst's timing & PoA →